Ackermans & Van Haaren NV (GB:0GYM) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Ackermans & van Haaren NV reports a strong third quarter in 2024, maintaining momentum with core participations like DEME and Delen Private Bank, and projects a net profit exceeding 400 million euros for the year. The company bolstered its portfolio with strategic investments in V.Group and Confo Therapeutics, while also increasing stakes in Nextensa and SIPEF. AvH’s financial position remains solid with a net cash position of 294.8 million euros as of September 2024.
For further insights into GB:0GYM stock, check out TipRanks’ Stock Analysis page.